Company intelligence / Profile preview

IQSynthesis

St. Louis, Missouri, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

IQ Synthesis is a contract research and development organization that provides specialized chemistry services to the pharmaceutical, biotechnology, and specialty chemical industries. The company focuses on custom organic synthesis, medicinal chemistry, and process research and development to support drug discovery and development programs. Their expertise includes the synthesis of complex small molecules, stable isotope-labeled compounds, and reference standards. Since its acquisition by EAG Laboratories (now part of Eurofins Scientific), IQ Synthesis operates as a specialized chemistry division within a global network of analytical and development services.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on IQSynthesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQSynthesis.

Explore the full profile